Skip to main content
Erschienen in: Documenta Ophthalmologica 1/2021

21.06.2020 | Clinical Case Report

Rod bipolar cell dysfunction in POLG retinopathy

verfasst von: Kit Green Sanderson, Eoghan Millar, Anupreet Tumber, Regan Klatt, Neal Sondheimer, Ajoy Vincent

Erschienen in: Documenta Ophthalmologica | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

To report the clinical and novel electrophysiological features in a child with POLG-related sensory ataxic neuropathy, dysarthria and ophthalmoparesis (SANDO).

Methods

The proband, a male child of Indian descent, underwent serial systemic and ophthalmological evaluations from birth until 14 years of age. Eye examinations included visual acuity and extraocular movement assessments, fundus photography, spectral domain optical coherence tomography and full-field electroretinography (ERG). Detailed genetic testing was also performed.

Results

The child carried a homozygous mutation in POLG (c.911T > G/p.Leu304Arg) and manifested systemic features such as seizures, headaches, areflexia, hypotonia, myopathy and vomiting. The child’s distance visual acuity was 0.50 and 0.40 LogMAR in the right and left eyes, respectively. Bilateral ophthalmoplegia and ptosis were observed at 5 years of age. The dark-adapted (DA) ERG responses to 2.29 cd s m−2 and 7.6 cd s m−2 stimuli showed a markedly reduced b/a ratio; an electronegative configuration was noted to a DA 7.6 ERG.

Conclusion

This is the first documented case of an electronegative ERG in a POLG-related disorder consistent with generalized rod ON-bipolar dysfunction. The rest of the proband’s systemic and ophthalmological features were consistent with SANDO but some features overlapped with other POLG-related disorders such as Alpers–Huttenlocher syndrome and autosomal dominant progressive external ophthalmoplegia demonstrating the wide phenotypic overlap expected due to POLG mutations.
Literatur
1.
Zurück zum Zitat Kong YX, Van Bergen N, Trounce IA, Bui BV, Chrysostomou V, Waugh H et al (2011) Increase in mitochondrial DNA mutations impairs retinal function and renders the retina vulnerable to injury. Aging Cell 10(4):572–583PubMed Kong YX, Van Bergen N, Trounce IA, Bui BV, Chrysostomou V, Waugh H et al (2011) Increase in mitochondrial DNA mutations impairs retinal function and renders the retina vulnerable to injury. Aging Cell 10(4):572–583PubMed
2.
Zurück zum Zitat DeBalsi KL, Hoff KE, Copeland WC (2017) Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases. Ageing Res Rev 33:89–104PubMed DeBalsi KL, Hoff KE, Copeland WC (2017) Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases. Ageing Res Rev 33:89–104PubMed
3.
Zurück zum Zitat Zheng W, Khrapko K, Coller HA, Thilly WG, Copeland WC (2006) Origins of human mitochondrial point mutations as DNA polymerase gamma-mediated errors. Mutat Res 599(1–2):11–20PubMed Zheng W, Khrapko K, Coller HA, Thilly WG, Copeland WC (2006) Origins of human mitochondrial point mutations as DNA polymerase gamma-mediated errors. Mutat Res 599(1–2):11–20PubMed
4.
Zurück zum Zitat Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE et al (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309(5733):481–484PubMed Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE et al (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309(5733):481–484PubMed
5.
Zurück zum Zitat Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE et al (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429(6990):417–423PubMed Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE et al (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429(6990):417–423PubMed
6.
Zurück zum Zitat Farnum GA, Nurminen A, Kaguni LS (2014) Mapping 136 pathogenic mutations into functional modules in human DNA polymerase gamma establishes predictive genotype-phenotype correlations for the complete spectrum of POLG syndromes. Biochim Biophys Acta 1837(7):1113–1121PubMedPubMedCentral Farnum GA, Nurminen A, Kaguni LS (2014) Mapping 136 pathogenic mutations into functional modules in human DNA polymerase gamma establishes predictive genotype-phenotype correlations for the complete spectrum of POLG syndromes. Biochim Biophys Acta 1837(7):1113–1121PubMedPubMedCentral
7.
Zurück zum Zitat Cohen BH, Chinnery PF, Copeland WC (1993) POLG-related disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. (eds) GeneReviews((R)). University of Washington, Seattle Cohen BH, Chinnery PF, Copeland WC (1993) POLG-related disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. (eds) GeneReviews((R)). University of Washington, Seattle
8.
Zurück zum Zitat Filosto M, Mancuso M, Nishigaki Y, Pancrudo J, Harati Y, Gooch C et al (2003) Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma. Arch Neurol 60(9):1279–1284PubMed Filosto M, Mancuso M, Nishigaki Y, Pancrudo J, Harati Y, Gooch C et al (2003) Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma. Arch Neurol 60(9):1279–1284PubMed
9.
Zurück zum Zitat Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM et al (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364(9437):875–882PubMed Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM et al (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364(9437):875–882PubMed
10.
Zurück zum Zitat Van Goethem G, Luoma P, Rantamaki M, Al Memar A, Kaakkola S, Hackman P et al (2004) POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 63(7):1251–1257PubMed Van Goethem G, Luoma P, Rantamaki M, Al Memar A, Kaakkola S, Hackman P et al (2004) POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 63(7):1251–1257PubMed
11.
Zurück zum Zitat Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28(3):211–212PubMed Van Goethem G, Dermaut B, Lofgren A, Martin JJ, Van Broeckhoven C (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28(3):211–212PubMed
12.
Zurück zum Zitat Van Goethem G, Martin JJ, Dermaut B, Lofgren A, Wibail A, Ververken D et al (2003) Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 13(2):133–142PubMed Van Goethem G, Martin JJ, Dermaut B, Lofgren A, Wibail A, Ververken D et al (2003) Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 13(2):133–142PubMed
13.
Zurück zum Zitat Lamantea E, Tiranti V, Bordoni A, Toscano A, Bono F, Servidei S et al (2002) Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 52(2):211–219PubMed Lamantea E, Tiranti V, Bordoni A, Toscano A, Bono F, Servidei S et al (2002) Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 52(2):211–219PubMed
14.
Zurück zum Zitat Saneto RP, Cohen BH, Copeland WC, Naviaux RK (2013) Alpers–Huttenlocher syndrome. Pediatr Neurol 48(3):167–178PubMedPubMedCentral Saneto RP, Cohen BH, Copeland WC, Naviaux RK (2013) Alpers–Huttenlocher syndrome. Pediatr Neurol 48(3):167–178PubMedPubMedCentral
15.
Zurück zum Zitat Harding BN (1990) Progressive neuronal degeneration of childhood with liver disease (Alpers–Huttenlocher syndrome): a personal review. J Child Neurol 5(4):273–287PubMed Harding BN (1990) Progressive neuronal degeneration of childhood with liver disease (Alpers–Huttenlocher syndrome): a personal review. J Child Neurol 5(4):273–287PubMed
16.
Zurück zum Zitat Worle H, Kohler B, Schlote W, Winkler P, Bastanier CK (1998) Progressive cerebral degeneration of childhood with liver disease (Alpers Huttenlocher disease) with cytochrome oxidase deficiency presenting with epilepsia partialis continua as the first clinical manifestation. Clin Neuropathol 17(2):63–68PubMed Worle H, Kohler B, Schlote W, Winkler P, Bastanier CK (1998) Progressive cerebral degeneration of childhood with liver disease (Alpers Huttenlocher disease) with cytochrome oxidase deficiency presenting with epilepsia partialis continua as the first clinical manifestation. Clin Neuropathol 17(2):63–68PubMed
17.
Zurück zum Zitat Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma PT, Rantamaki M et al (2005) Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 77(3):430–441PubMedPubMedCentral Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma PT, Rantamaki M et al (2005) Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 77(3):430–441PubMedPubMedCentral
18.
Zurück zum Zitat Di Fonzo A, Bordoni A, Crimi M, Sara G, Del Bo R, Bresolin N et al (2003) POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions. Hum Mutat 22(6):498–499PubMed Di Fonzo A, Bordoni A, Crimi M, Sara G, Del Bo R, Bresolin N et al (2003) POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions. Hum Mutat 22(6):498–499PubMed
19.
Zurück zum Zitat Audo I, Robson AG, Holder GE, Moore AT (2008) The negative ERG: clinical phenotypes and disease mechanisms of inner retinal dysfunction. Surv Ophthalmol 53(1):16–40PubMed Audo I, Robson AG, Holder GE, Moore AT (2008) The negative ERG: clinical phenotypes and disease mechanisms of inner retinal dysfunction. Surv Ophthalmol 53(1):16–40PubMed
20.
Zurück zum Zitat Nguyen KV, Sharief FS, Chan SS, Copeland WC, Naviaux RK (2006) Molecular diagnosis of Alpers syndrome. J Hepatol 45(1):108–116PubMed Nguyen KV, Sharief FS, Chan SS, Copeland WC, Naviaux RK (2006) Molecular diagnosis of Alpers syndrome. J Hepatol 45(1):108–116PubMed
21.
Zurück zum Zitat Boyd SG, Harden A, Egger J, Pampiglione G (1986) Progressive neuronal degeneration of childhood with liver disease ("Alpers' disease"): characteristic neurophysiological features. Neuropediatrics 17(2):75–80PubMed Boyd SG, Harden A, Egger J, Pampiglione G (1986) Progressive neuronal degeneration of childhood with liver disease ("Alpers' disease"): characteristic neurophysiological features. Neuropediatrics 17(2):75–80PubMed
22.
Zurück zum Zitat Marmor MF, Holder GE, Seeliger MW, Yamamoto S, International Society for Clinical Electrophysiology of V (2004) Standard for clinical electroretinography (2004 update). Doc Ophthalmol 108(2):107–114PubMed Marmor MF, Holder GE, Seeliger MW, Yamamoto S, International Society for Clinical Electrophysiology of V (2004) Standard for clinical electroretinography (2004 update). Doc Ophthalmol 108(2):107–114PubMed
23.
Zurück zum Zitat McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R et al (2015) ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1–12 McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R et al (2015) ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1–12
24.
Zurück zum Zitat Hanisch F, Kornhuber M, Alston CL, Taylor RW, Deschauer M, Zierz S (2015) SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions. J Neurol Neurosurg Psychiatry 86(6):630–634PubMed Hanisch F, Kornhuber M, Alston CL, Taylor RW, Deschauer M, Zierz S (2015) SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions. J Neurol Neurosurg Psychiatry 86(6):630–634PubMed
25.
Zurück zum Zitat Wong LJ, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C et al (2008) Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29(9):E150–E172PubMedPubMedCentral Wong LJ, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C et al (2008) Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29(9):E150–E172PubMedPubMedCentral
26.
Zurück zum Zitat Finsterer J, Zarrouk MS (2012) Epilepsy in mitochondrial disorders. Seizure 21(5):316–321PubMed Finsterer J, Zarrouk MS (2012) Epilepsy in mitochondrial disorders. Seizure 21(5):316–321PubMed
27.
Zurück zum Zitat Fadic R, Russell JA, Vedanarayanan VV, Lehar M, Kuncl RW, Johns DR (1997) Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 49(1):239–245PubMed Fadic R, Russell JA, Vedanarayanan VV, Lehar M, Kuncl RW, Johns DR (1997) Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 49(1):239–245PubMed
28.
Zurück zum Zitat Young MJ, Longley MJ, Li FY, Kasiviswanathan R, Wong LJ, Copeland WC (2011) Biochemical analysis of human POLG2 variants associated with mitochondrial disease. Hum Mol Genet 20(15):3052–3066PubMedPubMedCentral Young MJ, Longley MJ, Li FY, Kasiviswanathan R, Wong LJ, Copeland WC (2011) Biochemical analysis of human POLG2 variants associated with mitochondrial disease. Hum Mol Genet 20(15):3052–3066PubMedPubMedCentral
29.
Zurück zum Zitat Milone M, Massie R (2010) Polymerase gamma 1 mutations: clinical correlations. Neurologist 16(2):84–91PubMed Milone M, Massie R (2010) Polymerase gamma 1 mutations: clinical correlations. Neurologist 16(2):84–91PubMed
30.
Zurück zum Zitat Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129(Pt 7):1685–1692PubMed Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129(Pt 7):1685–1692PubMed
31.
Zurück zum Zitat Stumpf JD, Saneto RP, Copeland WC (2013) Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harb Perspect Biol 5(4):a011395PubMedPubMedCentral Stumpf JD, Saneto RP, Copeland WC (2013) Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harb Perspect Biol 5(4):a011395PubMedPubMedCentral
32.
Zurück zum Zitat Pagnamenta AT, Taanman JW, Wilson CJ, Anderson NE, Marotta R, Duncan AJ et al (2006) Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum Reprod 21(10):2467–2473PubMed Pagnamenta AT, Taanman JW, Wilson CJ, Anderson NE, Marotta R, Duncan AJ et al (2006) Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum Reprod 21(10):2467–2473PubMed
33.
Zurück zum Zitat Pillers DA, Fitzgerald KM, Duncan NM, Rash SM, White RA, Dwinnell SJ et al (1999) Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations. Hum Genet 105(1–2):2–9 Pillers DA, Fitzgerald KM, Duncan NM, Rash SM, White RA, Dwinnell SJ et al (1999) Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations. Hum Genet 105(1–2):2–9
34.
Zurück zum Zitat Rahman S, Copeland WC (2019) POLG-related disorders and their neurological manifestations. Nat Rev Neurol 15(1):40–52PubMed Rahman S, Copeland WC (2019) POLG-related disorders and their neurological manifestations. Nat Rev Neurol 15(1):40–52PubMed
35.
Zurück zum Zitat Naimi M, Bannwarth S, Procaccio V, Pouget J, Desnuelle C, Pellissier JF et al (2006) Molecular analysis of ANT1, TWINKLE and POLG in patients with multiple deletions or depletion of mitochondrial DNA by a dHPLC-based assay. Eur J Hum Genet 14(8):917–922PubMed Naimi M, Bannwarth S, Procaccio V, Pouget J, Desnuelle C, Pellissier JF et al (2006) Molecular analysis of ANT1, TWINKLE and POLG in patients with multiple deletions or depletion of mitochondrial DNA by a dHPLC-based assay. Eur J Hum Genet 14(8):917–922PubMed
36.
Zurück zum Zitat Tang S, Wang J, Lee NC, Milone M, Halberg MC, Schmitt ES et al (2011) Mitochondrial DNA polymerase gamma mutations: an ever expanding molecular and clinical spectrum. J Med Genet 48(10):669–681PubMed Tang S, Wang J, Lee NC, Milone M, Halberg MC, Schmitt ES et al (2011) Mitochondrial DNA polymerase gamma mutations: an ever expanding molecular and clinical spectrum. J Med Genet 48(10):669–681PubMed
37.
Zurück zum Zitat Sonam K, Bindu PS, Srinivas Bharath MM, Govindaraj P, Gayathri N, Arvinda HR et al (2017) Mitochondrial oxidative phosphorylation disorders in children: phenotypic, genotypic and biochemical correlations in 85 patients from South India. Mitochondrion 32:42–49PubMed Sonam K, Bindu PS, Srinivas Bharath MM, Govindaraj P, Gayathri N, Arvinda HR et al (2017) Mitochondrial oxidative phosphorylation disorders in children: phenotypic, genotypic and biochemical correlations in 85 patients from South India. Mitochondrion 32:42–49PubMed
38.
Zurück zum Zitat Rouzier C, Chaussenot A, Serre V, Fragaki K, Bannwarth S, Ait-El-Mkadem S et al (2014) Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort. Eur J Hum Genet 22(4):542–550PubMed Rouzier C, Chaussenot A, Serre V, Fragaki K, Bannwarth S, Ait-El-Mkadem S et al (2014) Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort. Eur J Hum Genet 22(4):542–550PubMed
39.
Zurück zum Zitat Stewart JD, Horvath R, Baruffini E, Ferrero I, Bulst S, Watkins PB et al (2010) Polymerase gamma gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology 52(5):1791–1796PubMed Stewart JD, Horvath R, Baruffini E, Ferrero I, Bulst S, Watkins PB et al (2010) Polymerase gamma gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology 52(5):1791–1796PubMed
40.
Zurück zum Zitat Navarro-Sastre A, Tort F, Garcia-Villoria J, Pons MR, Nascimento A, Colomer J et al (2012) Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients. Mol Genet Metab 107(3):409–415PubMed Navarro-Sastre A, Tort F, Garcia-Villoria J, Pons MR, Nascimento A, Colomer J et al (2012) Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients. Mol Genet Metab 107(3):409–415PubMed
41.
Zurück zum Zitat Cardenas JF, Amato RS (2010) Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease. Semin Pediatr Neurol 17(1):62–64PubMed Cardenas JF, Amato RS (2010) Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease. Semin Pediatr Neurol 17(1):62–64PubMed
42.
Zurück zum Zitat Scuderi C, Borgione E, Castello F, Lo Giudice M, Santa Paola S, Giambirtone M et al (2015) The in cis T251I and P587L POLG1 base changes: description of a new family and literature review. Neuromuscul Disord 25(4):333–339PubMed Scuderi C, Borgione E, Castello F, Lo Giudice M, Santa Paola S, Giambirtone M et al (2015) The in cis T251I and P587L POLG1 base changes: description of a new family and literature review. Neuromuscul Disord 25(4):333–339PubMed
43.
Zurück zum Zitat Horvath R, Hudson G, Ferrari G, Futterer N, Ahola S, Lamantea E et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129(Pt 7):1674–1684PubMed Horvath R, Hudson G, Ferrari G, Futterer N, Ahola S, Lamantea E et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129(Pt 7):1674–1684PubMed
Metadaten
Titel
Rod bipolar cell dysfunction in POLG retinopathy
verfasst von
Kit Green Sanderson
Eoghan Millar
Anupreet Tumber
Regan Klatt
Neal Sondheimer
Ajoy Vincent
Publikationsdatum
21.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 1/2021
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-020-09777-w

Weitere Artikel der Ausgabe 1/2021

Documenta Ophthalmologica 1/2021 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.